GO:0035019 | somatic stem cell maintenance | 1.12e-04 | 1.00e+00 | 6.909 | 2 | 6 | 40 |
GO:0019901 | protein kinase binding | 2.00e-04 | 1.00e+00 | 4.508 | 3 | 18 | 317 |
GO:0008013 | beta-catenin binding | 2.53e-04 | 1.00e+00 | 6.324 | 2 | 9 | 60 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0023057 | negative regulation of signaling | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0072376 | protein activation cascade | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0051435 | BH4 domain binding | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 4.16e-04 | 1.00e+00 | 11.231 | 1 | 1 | 1 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 2 |
GO:0009798 | axis specification | 8.32e-04 | 1.00e+00 | 10.231 | 1 | 1 | 2 |
GO:0030027 | lamellipodium | 1.09e-03 | 1.00e+00 | 5.265 | 2 | 7 | 125 |
GO:0060913 | cardiac cell fate determination | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 3 |
GO:0038127 | ERBB signaling pathway | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 4 |
GO:0019887 | protein kinase regulator activity | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 4 |
GO:0001714 | endodermal cell fate specification | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 1 | 5 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 2.08e-03 | 1.00e+00 | 8.909 | 1 | 2 | 5 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 2.47e-03 | 1.00e+00 | 4.669 | 2 | 5 | 189 |
GO:0030858 | positive regulation of epithelial cell differentiation | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 6 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 2 | 7 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 2 | 7 |
GO:0070102 | interleukin-6-mediated signaling pathway | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 7 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 7 |
GO:0045670 | regulation of osteoclast differentiation | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 2 | 8 |
GO:0007172 | signal complex assembly | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 8 |
GO:0060396 | growth hormone receptor signaling pathway | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 8 |
GO:0045667 | regulation of osteoblast differentiation | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 9 |
GO:0031953 | negative regulation of protein autophosphorylation | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 9 |
GO:0060711 | labyrinthine layer development | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 3 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 10 |
GO:0030877 | beta-catenin destruction complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 10 |
GO:0031116 | positive regulation of microtubule polymerization | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 11 |
GO:0051010 | microtubule plus-end binding | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 11 |
GO:0017166 | vinculin binding | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 4 | 11 |
GO:0045295 | gamma-catenin binding | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 12 |
GO:0032886 | regulation of microtubule-based process | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 12 |
GO:0005515 | protein binding | 5.30e-03 | 1.00e+00 | 1.260 | 6 | 198 | 6024 |
GO:0044295 | axonal growth cone | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 2 | 13 |
GO:0043409 | negative regulation of MAPK cascade | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 2 | 13 |
GO:0005737 | cytoplasm | 5.70e-03 | 1.00e+00 | 1.674 | 5 | 124 | 3767 |
GO:0035371 | microtubule plus-end | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 14 |
GO:0034614 | cellular response to reactive oxygen species | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 2 | 14 |
GO:0001824 | blastocyst development | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 2 | 15 |
GO:0007026 | negative regulation of microtubule depolymerization | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 16 |
GO:0043274 | phospholipase binding | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 16 |
GO:0051276 | chromosome organization | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 16 |
GO:0008283 | cell proliferation | 7.28e-03 | 1.00e+00 | 3.874 | 2 | 14 | 328 |
GO:0031122 | cytoplasmic microtubule organization | 7.47e-03 | 1.00e+00 | 7.061 | 1 | 1 | 18 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 7.88e-03 | 1.00e+00 | 6.983 | 1 | 2 | 19 |
GO:0048041 | focal adhesion assembly | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 21 |
GO:0009954 | proximal/distal pattern formation | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 21 |
GO:0000281 | mitotic cytokinesis | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 2 | 21 |
GO:0007155 | cell adhesion | 9.15e-03 | 1.00e+00 | 3.704 | 2 | 5 | 369 |
GO:0045296 | cadherin binding | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 3 | 24 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 2 | 27 |
GO:0048754 | branching morphogenesis of an epithelial tube | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 1 | 27 |
GO:0005875 | microtubule associated complex | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 28 |
GO:0070830 | tight junction assembly | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 28 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.17e-02 | 1.00e+00 | 3.520 | 2 | 30 | 419 |
GO:0030032 | lamellipodium assembly | 1.20e-02 | 1.00e+00 | 6.373 | 1 | 1 | 29 |
GO:0005913 | cell-cell adherens junction | 1.20e-02 | 1.00e+00 | 6.373 | 1 | 3 | 29 |
GO:0009953 | dorsal/ventral pattern formation | 1.28e-02 | 1.00e+00 | 6.277 | 1 | 2 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 1.28e-02 | 1.00e+00 | 6.277 | 1 | 3 | 31 |
GO:0033077 | T cell differentiation in thymus | 1.37e-02 | 1.00e+00 | 6.187 | 1 | 1 | 33 |
GO:0001942 | hair follicle development | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 2 | 35 |
GO:0034446 | substrate adhesion-dependent cell spreading | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 36 |
GO:0048538 | thymus development | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 2 | 36 |
GO:0007257 | activation of JUN kinase activity | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 5 | 36 |
GO:0051781 | positive regulation of cell division | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 39 |
GO:0005881 | cytoplasmic microtubule | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 40 |
GO:0045785 | positive regulation of cell adhesion | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 40 |
GO:0031124 | mRNA 3'-end processing | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 42 |
GO:0006369 | termination of RNA polymerase II transcription | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 2 | 45 |
GO:0016328 | lateral plasma membrane | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 3 | 46 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 1.94e-02 | 1.00e+00 | 5.677 | 1 | 2 | 47 |
GO:0005070 | SH3/SH2 adaptor activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 48 |
GO:0030334 | regulation of cell migration | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 5 | 50 |
GO:0045732 | positive regulation of protein catabolic process | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 1 | 50 |
GO:0060041 | retina development in camera-type eye | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 2 | 51 |
GO:0051028 | mRNA transport | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 4 | 52 |
GO:0009611 | response to wounding | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 5 | 52 |
GO:0001725 | stress fiber | 2.27e-02 | 1.00e+00 | 5.450 | 1 | 4 | 55 |
GO:0005643 | nuclear pore | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 11 | 57 |
GO:0006406 | mRNA export from nucleus | 2.51e-02 | 1.00e+00 | 5.300 | 1 | 4 | 61 |
GO:0019903 | protein phosphatase binding | 2.55e-02 | 1.00e+00 | 5.277 | 1 | 2 | 62 |
GO:0000776 | kinetochore | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 5 | 63 |
GO:0007409 | axonogenesis | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 65 |
GO:0010468 | regulation of gene expression | 2.80e-02 | 1.00e+00 | 5.144 | 1 | 2 | 68 |
GO:0034329 | cell junction assembly | 2.80e-02 | 1.00e+00 | 5.144 | 1 | 3 | 68 |
GO:0008544 | epidermis development | 2.84e-02 | 1.00e+00 | 5.123 | 1 | 1 | 69 |
GO:0032587 | ruffle membrane | 2.88e-02 | 1.00e+00 | 5.102 | 1 | 3 | 70 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 3.04e-02 | 1.00e+00 | 5.022 | 1 | 4 | 74 |
GO:0060070 | canonical Wnt signaling pathway | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 4 | 75 |
GO:0001822 | kidney development | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 3 | 78 |
GO:0007229 | integrin-mediated signaling pathway | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 3 | 78 |
GO:0009653 | anatomical structure morphogenesis | 3.40e-02 | 1.00e+00 | 4.856 | 1 | 2 | 83 |
GO:0009952 | anterior/posterior pattern specification | 3.40e-02 | 1.00e+00 | 4.856 | 1 | 4 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 3.53e-02 | 1.00e+00 | 4.805 | 1 | 8 | 86 |
GO:0005923 | tight junction | 3.53e-02 | 1.00e+00 | 4.805 | 1 | 2 | 86 |
GO:0006979 | response to oxidative stress | 3.57e-02 | 1.00e+00 | 4.788 | 1 | 6 | 87 |
GO:0006936 | muscle contraction | 3.57e-02 | 1.00e+00 | 4.788 | 1 | 3 | 87 |
GO:0000187 | activation of MAPK activity | 3.69e-02 | 1.00e+00 | 4.739 | 1 | 3 | 90 |
GO:0007010 | cytoskeleton organization | 3.73e-02 | 1.00e+00 | 4.723 | 1 | 4 | 91 |
GO:0006928 | cellular component movement | 3.73e-02 | 1.00e+00 | 4.723 | 1 | 3 | 91 |
GO:0005178 | integrin binding | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 4 | 96 |
GO:0008360 | regulation of cell shape | 4.21e-02 | 1.00e+00 | 4.545 | 1 | 4 | 103 |
GO:0005938 | cell cortex | 4.25e-02 | 1.00e+00 | 4.531 | 1 | 5 | 104 |
GO:0006461 | protein complex assembly | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 4 | 111 |
GO:0030529 | ribonucleoprotein complex | 4.57e-02 | 1.00e+00 | 4.424 | 1 | 5 | 112 |
GO:0048015 | phosphatidylinositol-mediated signaling | 4.65e-02 | 1.00e+00 | 4.398 | 1 | 2 | 114 |
GO:0007050 | cell cycle arrest | 5.05e-02 | 1.00e+00 | 4.277 | 1 | 5 | 124 |
GO:0030335 | positive regulation of cell migration | 5.17e-02 | 1.00e+00 | 4.242 | 1 | 5 | 127 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 5.21e-02 | 1.00e+00 | 4.231 | 1 | 11 | 128 |
GO:0016477 | cell migration | 5.21e-02 | 1.00e+00 | 4.231 | 1 | 4 | 128 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 5.37e-02 | 1.00e+00 | 4.187 | 1 | 4 | 132 |
GO:0007507 | heart development | 5.65e-02 | 1.00e+00 | 4.112 | 1 | 7 | 139 |
GO:0008286 | insulin receptor signaling pathway | 5.76e-02 | 1.00e+00 | 4.081 | 1 | 1 | 142 |
GO:0008017 | microtubule binding | 5.96e-02 | 1.00e+00 | 4.031 | 1 | 2 | 147 |
GO:0006974 | cellular response to DNA damage stimulus | 6.12e-02 | 1.00e+00 | 3.993 | 1 | 7 | 151 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 6.32e-02 | 1.00e+00 | 3.946 | 1 | 1 | 156 |
GO:0044822 | poly(A) RNA binding | 6.59e-02 | 1.00e+00 | 2.187 | 2 | 50 | 1056 |
GO:0000398 | mRNA splicing, via spliceosome | 6.63e-02 | 1.00e+00 | 3.874 | 1 | 15 | 164 |
GO:0044212 | transcription regulatory region DNA binding | 6.79e-02 | 1.00e+00 | 3.839 | 1 | 17 | 168 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 6.79e-02 | 1.00e+00 | 3.839 | 1 | 5 | 168 |
GO:0005829 | cytosol | 6.86e-02 | 1.00e+00 | 1.531 | 3 | 86 | 2496 |
GO:0005654 | nucleoplasm | 6.89e-02 | 1.00e+00 | 2.152 | 2 | 64 | 1082 |
GO:0016607 | nuclear speck | 6.95e-02 | 1.00e+00 | 3.805 | 1 | 12 | 172 |
GO:0005667 | transcription factor complex | 7.06e-02 | 1.00e+00 | 3.780 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 7.18e-02 | 1.00e+00 | 3.755 | 1 | 5 | 178 |
GO:0004871 | signal transducer activity | 8.35e-02 | 1.00e+00 | 3.531 | 1 | 4 | 208 |
GO:0005634 | nucleus | 8.39e-02 | 1.00e+00 | 1.077 | 4 | 159 | 4559 |
GO:0008380 | RNA splicing | 9.12e-02 | 1.00e+00 | 3.398 | 1 | 22 | 228 |
GO:0008134 | transcription factor binding | 9.66e-02 | 1.00e+00 | 3.312 | 1 | 18 | 242 |
GO:0000166 | nucleotide binding | 1.03e-01 | 1.00e+00 | 3.214 | 1 | 13 | 259 |
GO:0043065 | positive regulation of apoptotic process | 1.06e-01 | 1.00e+00 | 3.165 | 1 | 7 | 268 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.07e-01 | 1.00e+00 | 3.160 | 1 | 7 | 269 |
GO:0005856 | cytoskeleton | 1.15e-01 | 1.00e+00 | 3.046 | 1 | 9 | 291 |
GO:0005813 | centrosome | 1.28e-01 | 1.00e+00 | 2.882 | 1 | 7 | 326 |
GO:0015031 | protein transport | 1.34e-01 | 1.00e+00 | 2.817 | 1 | 11 | 341 |
GO:0003723 | RNA binding | 1.34e-01 | 1.00e+00 | 2.813 | 1 | 18 | 342 |
GO:0043565 | sequence-specific DNA binding | 1.36e-01 | 1.00e+00 | 2.796 | 1 | 11 | 346 |
GO:0008285 | negative regulation of cell proliferation | 1.38e-01 | 1.00e+00 | 2.768 | 1 | 10 | 353 |
GO:0005925 | focal adhesion | 1.43e-01 | 1.00e+00 | 2.715 | 1 | 9 | 366 |
GO:0048471 | perinuclear region of cytoplasm | 1.92e-01 | 1.00e+00 | 2.260 | 1 | 8 | 502 |
GO:0006915 | apoptotic process | 2.10e-01 | 1.00e+00 | 2.115 | 1 | 12 | 555 |
GO:0045087 | innate immune response | 2.24e-01 | 1.00e+00 | 2.012 | 1 | 15 | 596 |
GO:0010467 | gene expression | 2.48e-01 | 1.00e+00 | 1.845 | 1 | 45 | 669 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.58e-01 | 1.00e+00 | 1.782 | 1 | 39 | 699 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.87e-01 | 1.00e+00 | 1.607 | 1 | 41 | 789 |
GO:0005886 | plasma membrane | 2.93e-01 | 1.00e+00 | 0.897 | 2 | 49 | 2582 |
GO:0007165 | signal transduction | 3.23e-01 | 1.00e+00 | 1.406 | 1 | 13 | 907 |
GO:0006355 | regulation of transcription, DNA-templated | 3.49e-01 | 1.00e+00 | 1.270 | 1 | 43 | 997 |
GO:0008270 | zinc ion binding | 3.49e-01 | 1.00e+00 | 1.270 | 1 | 27 | 997 |
GO:0003677 | DNA binding | 4.11e-01 | 1.00e+00 | 0.981 | 1 | 49 | 1218 |
GO:0005730 | nucleolus | 5.16e-01 | 1.00e+00 | 0.551 | 1 | 66 | 1641 |
GO:0016020 | membrane | 5.25e-01 | 1.00e+00 | 0.516 | 1 | 46 | 1681 |
GO:0070062 | extracellular vesicular exosome | 6.65e-01 | 1.00e+00 | 0.002 | 1 | 57 | 2400 |